Expanding Applications Beyond Traditional Cancer Types Innovation is rapidly expanding possibilities within the Radioligand Therapy (RLT) Market. Initially developed for specific tumor categories, researchers are now exploring applications across a broader range of cancers. Prostate cancer treatments have demonstrated strong success using receptor-targeted ligands. These outcomes encouraged scientists to investigate additional molecular targets found in breast, lung, and pancreatic cancers. Advances in molecular biology allow researchers to identify tumor-specific proteins more effectively. Once suitable targets are discovered, ligands can be designed to deliver radiation directly to malignant cells. Ref - https://www.marketresearchfuture.com/reports/radioligand-therapy-rlt-market-11824